Top

Clinical Oral Investigations

Published in:

01-09-2017 | Original Article

Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study

Authors: Takuya Asaka, Noritaka Ohga, Yutaka Yamazaki, Jun Sato, Chiharu Satoh, Yoshimasa Kitagawa

Published in: Clinical Oral Investigations | Issue 7/2017

Abstract

Objectives

The aim of the present study was to evaluate the effectiveness of platelet-rich fibrin (PRF) as a wound-healing accelerator in patients undergoing oral bisphosphonate therapy and requiring tooth extractions.

Materials and methods

A total of 102 patients were divided into a PRF group and control group. The patients received oral bisphosphonate therapy for osteoporosis for an average of 32 months. Blood was collected and PRF was introduced into the socket of the PRF group only. Monitoring of mucosal healing was conducted for 3 months in both groups, and radiographic evaluation in the sockets was performed in the PRF group. Delayed recovery was defined as exposed bone and vulnerable granulation tissue without epithelization after 4 weeks and resolving by 8 weeks.

Results

There were no intraoperative complications, and none of the patients exhibited onset of medication-related osteonecrosis of the jaw (MRONJ). Delayed recovery was observed in 9 out of 73 control patients (12%), whereas 29 PRF patients exhibited complete epithelialization of the socket within 1 month. The prevalence of delayed recovery was significantly higher in the control group than the PRF group (P < 0.05). Multivariate logistic regression analysis revealed that risk factors and use of PRF were independent significant factors to relate to delayed recovery (P = 0.02).

Conclusions

Early epithelization was confirmed in all PRF patients. Thus, PRF may reduce the risk of delayed recovery in patients undergoing oral bisphosphonate therapy.

Clinical relevance

PRF may be useful in preventing MRONJ in patients receiving oral bisphosphonate (BP).

Available only for authorised users

Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72:1938CrossRefPubMed

Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65(3):415–423CrossRefPubMed

Urade M, Tanaka N, Furusawa K et al (2011) Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan. J Oral Maxillofac Surg 69(11):e364–e371CrossRefPubMed

Yamazaki Y, Sato J, Kitagawa Y et al (2011) A retrospective study of the healing process after tooth extraction in patients receiving oral bisphosphonates for more than 3 years. (Japanese manuscript with English abstracts). Jpn J Oral Maxillofac Surg 57(12):658–665CrossRef

Yamazaki Y, Sato J, Kitagawa Y et al (2014) A retrospective study of the healing process after tooth extraction in patients receiving oral bisphosphonates. (Japanese manuscript with English abstracts). Jpn J Oral Maxillofac Surg 60(9):514–521CrossRef

Marx RE, Carlson ER, Eichstaedt RM (2009) Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:638–646CrossRef

Del Fabbro M, Gallesio G, Mozzati M (2015) Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. Eur J Cancer 51(1):62–74CrossRefPubMed

Dohan EDM, Rasmusson L, Albrektsson Y (1998) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27:158–167CrossRef

Mazzocca AD, McCarthy MBR, Chowaniec DM et al (2012) Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 94:308–316CrossRefPubMed

10.

Anitua E, Alkhraisat MH, Orive G (2012) Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release 157:29–38CrossRefPubMed

11.

Soydan SS, Uckan S (2014) Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report. J Oral Maxillofac Surg 72(2):322–326CrossRefPubMed

12.

Mozzati M, Arata V, Gallesio G (2012b) Tooth extraction in patients on zoledronic acid therapy. Oral Oncol 48(9):817–821CrossRefPubMed

13.

Kim JW, Kim SJ, Kim MR (2014) Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study. Br J Oral Maxillofac Surg 52(9):854–859CrossRefPubMed

14.

Landesberg R, Cozin M, Cremers S et al (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66(5):839–847CrossRefPubMedPubMedCentral

15.

Mozzati M, Gallesio G, Arata V et al (2012a) Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol 48(5):469–474CrossRefPubMed

16.

Cetiner S, Sucak GT, Kahraman SA et al (2009) Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab 27(4):435–443CrossRefPubMed

17.

Curi MM, Cossolin GS, Koga DH et al (2011) Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J Oral Maxillofac Surg 69(9):2465–2472CrossRefPubMed

18.

Longo F, Guida A, Aversa C et al (2014) Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent 2014:298945CrossRefPubMedPubMedCentral

19.

Bocanegra-Pérez S, Vicente-Barrero M, Knezevic M et al (2012) Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg 41(11):1410–1415CrossRefPubMed

20.

Dohan DM, Choukroun J, Diss A et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate—part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:e45–e50CrossRefPubMed

21.

Choukroun J, Diss A, Simonpieri A et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:e56–e60CrossRefPubMed

22.

Pripatnanont P, Nuntanaranont T, Vongvatcharanon S et al (2013) The primacy of platelet-rich fibrin on bone regeneration of various grafts in rabbit’s calvarial defects. I J Craniomaxillofac Surg 41(8):e191–e200CrossRefPubMed

23.

Dohan Ehrenfest DM, de Peppo GM, Doglioli P et al (2009) Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 27(1):63–69CrossRefPubMed

24.

He L, Lin Y, Hu X et al (2009) A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108(5):707–713CrossRefPubMed

25.

Mozzati M, Arata V, Gallesio G (2013) Tooth extraction in osteoporotic patients taking oral bisphosphonates. Osteoporos Int 24(5):1707–1712CrossRefPubMed

Title: Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study
Authors: Takuya Asaka
Noritaka Ohga
Yutaka Yamazaki
Jun Sato
Chiharu Satoh
Yoshimasa Kitagawa
Publication date: 01-09-2017
Publisher: Springer Berlin Heidelberg
Published in: Clinical Oral Investigations / Issue 7/2017
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-016-2004-z

At a glance: The STEP trials

Springer Medicine

Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

At a glance: The STEP trials

Springer Medicine

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Please log in to get access to this content

Other articles of this Issue 7/2017

Salivary oxidative stress biomarkers in chronic periodontitis and acute coronary syndrome

More on molar incisor hypomineralisation (MIH) and linear enamel hypoplasia (LEH) in archaeological human remains

Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study

Oral appliance therapy versus nasal continuous positive airway pressure in obstructive sleep apnea: a randomized, placebo-controlled trial on psychological distress

Tracking of the inferior alveolar nerve: its implication in surgical planning

Efficacy of desensitizing products containing 8% arginine and calcium carbonate for hypersensitivity relief in MIH-affected molars: an 8-week clinical study